ALZHEIMER'S DISEASE: PATHOGENESIS, CLINICAL MANIFESTATIONS, EARLY DIAGNOSIS, AND EMERGING THERAPEUTIC APPROACHES
DOI:
https://doi.org/10.5281/zenodo.20596920Keywords:
Alzheimer’s disease; dementia; neurodegeneration; amyloid-beta; tau protein; cognitive impairment; early diagnosis; biomarkers; emerging therapies.Abstract
Alzheimer’s disease (AD) is the most common cause of dementia and represents a major global health challenge due to the aging population. It is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, behavioral disturbances, and loss of functional independence. The disease develops gradually over many years before clinical symptoms become apparent, making early diagnosis particularly important. Although the exact etiology remains incompletely understood, advances in neuroscience have significantly improved our understanding of the molecular mechanisms underlying the disease. This article reviews the pathogenesis of Alzheimer’s disease, discusses its clinical manifestations, highlights current approaches to early diagnosis, and examines emerging therapeutic strategies aimed at slowing disease progression and improving patient outcomes.
References
Uzbek Literature
1.Rahimov, R.A. Nevrologiya. Toshkent: Yangi asr avlodi, 2021.
2.Mamatqulov, M.A. Patologik fiziologiya. Toshkent: Fan va texnologiya, 2018.
3.Karimov, H.Q. Geriatriya va gerontologiya asoslari. Toshkent: Abu Ali ibn Sino nomidagi Tibbiyot nashriyoti, 2020.
International Literature
1.Alzheimer's Association. 2025 Alzheimer’s Disease Facts and Figures. Chicago, 2025.
2.National Institute on Aging. Alzheimer’s Disease Research and Clinical Guidelines. Bethesda, 2024.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal